TY - JOUR
T1 - Exploration of Cytotoxicity and Antibacterial Activities of M-Ceo2 (M = Ag, Cu, Te, and Ta) Nanoparticles
AU - Qureshi, Faiza
AU - Aljameel, Suhailah S.
AU - Nawaz, Muhammad
AU - Ansari, Mohammad Azam
AU - Khan, Firdos Alam
AU - Akhtar, Sultan
AU - Alsayed, Mariam Ali
AU - Akbar, Mohammad J.
AU - Muzaheed,
N1 - Publisher Copyright:
© 2025 The Author(s). ChemistryOpen published by Wiley-VCH GmbH.
PY - 2025/12
Y1 - 2025/12
N2 - This study focuses on the ultrasonic synthesis of M-CeO2 (M = Ag, Cu, Te & Ta) nanoparticles (NPs) and screening of their cytotoxicity and antibacterial activities. The prepared NPs are characterized by different techniques such as X-ray diffraction, transmission electron microscope, SEM-EDX,DR-UV-visible spectrophotometer, and dynamic light scattering analysis. The cytotoxicity of M-CeO2 nanoparticles are assessed against cancer cells such as colorectal carcinoma (HCT-116) and cervical cancer cells (HeLa) and non-cancer cells (embryonic kidney cells HEK-293). The effect of post-48 h treatment of CeO2, Ag-CeO2, Cu-CeO2, Te-CeO2, and Ta-CeO2, on HCT-116 and HeLa cells showed a noteworthy reduction in cell viability. The treatments of Ag-CeO2 also display a reduction in cancer cell viability but statistically not significant. The treatment of CeO2 shows better inhibitory action on HCT-116 and HeLa cells. HEK-293 is treated with CeO2, Ag-CeO2, Cu-CeO2, Te-CeO2, and Ta-CeO2 NPs with the same dosages, there is a minor decline in the cell number, but the percentage of cells viability is greater than HCT-116 and HeLa cells. The antibacterial activity of NPs against E. coli and S. aureus is tested, and Te-CeO2 NPs show better antibacterial activity. The lowest MIC displayed by Te-CeO2 is 0.25 mg mL−1 against E. coli and 4 mg mL−1 for S. aureus, respectively.
AB - This study focuses on the ultrasonic synthesis of M-CeO2 (M = Ag, Cu, Te & Ta) nanoparticles (NPs) and screening of their cytotoxicity and antibacterial activities. The prepared NPs are characterized by different techniques such as X-ray diffraction, transmission electron microscope, SEM-EDX,DR-UV-visible spectrophotometer, and dynamic light scattering analysis. The cytotoxicity of M-CeO2 nanoparticles are assessed against cancer cells such as colorectal carcinoma (HCT-116) and cervical cancer cells (HeLa) and non-cancer cells (embryonic kidney cells HEK-293). The effect of post-48 h treatment of CeO2, Ag-CeO2, Cu-CeO2, Te-CeO2, and Ta-CeO2, on HCT-116 and HeLa cells showed a noteworthy reduction in cell viability. The treatments of Ag-CeO2 also display a reduction in cancer cell viability but statistically not significant. The treatment of CeO2 shows better inhibitory action on HCT-116 and HeLa cells. HEK-293 is treated with CeO2, Ag-CeO2, Cu-CeO2, Te-CeO2, and Ta-CeO2 NPs with the same dosages, there is a minor decline in the cell number, but the percentage of cells viability is greater than HCT-116 and HeLa cells. The antibacterial activity of NPs against E. coli and S. aureus is tested, and Te-CeO2 NPs show better antibacterial activity. The lowest MIC displayed by Te-CeO2 is 0.25 mg mL−1 against E. coli and 4 mg mL−1 for S. aureus, respectively.
KW - antibacterial
KW - ceO
KW - cytotoxicity
KW - nanoparticles
UR - https://www.scopus.com/pages/publications/105015540651
U2 - 10.1002/open.202500278
DO - 10.1002/open.202500278
M3 - Article
AN - SCOPUS:105015540651
SN - 2191-1363
VL - 14
JO - ChemistryOpen
JF - ChemistryOpen
IS - 12
M1 - e202500278
ER -